argenx files Form 6-K with press release, presentation

argenx SE filed a Form 6-K as a foreign private issuer to furnish investors with a new press release and an investor presentation dated October 30, 2025.

Rhea-AI Filing Summary

argenx SE filed a Form 6-K as a foreign private issuer to furnish investors with a new press release and an investor presentation dated October 30, 2025. These documents are attached as Exhibits 99.1 and 99.2 and provide updated company information for the market.

The furnished materials are also incorporated by reference into argenx’s existing Form S-8 registration statements, becoming part of those filings from the date this Form 6-K is filed, unless later superseded. This ties the latest investor communications directly into the company’s equity compensation registration framework.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does argenx (ARGX) report in its October 2025 Form 6-K?

argenx SE filed a Form 6-K to furnish a press release and investor presentation dated October 30, 2025. These materials provide updated company information and are attached as Exhibits 99.1 and 99.2 for investors.

How does this argenx (ARGX) Form 6-K affect its S-8 registration statements?

The Form 6-K incorporates the press release and investor presentation by reference into argenx’s existing Form S-8 registration statements. They become part of those registrations from the Form 6-K filing date, unless later filings supersede them.

What documents are attached to argenx’s October 30, 2025 Form 6-K?

The Form 6-K includes two exhibits: a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2), both dated October 30, 2025. These documents contain the substantive information referenced in the report.

Why does argenx (ARGX) use Form 6-K as a foreign private issuer?

As a foreign private issuer, argenx uses Form 6-K to furnish important information to U.S. investors under the Securities Exchange Act. This form allows the company to share press releases and presentations with the U.S. market.

Who signed argenx’s October 2025 Form 6-K filing?

The Form 6-K was signed on behalf of argenx by Hemamalini (Malini) Moorthy, its General Counsel. Her signature confirms the company’s authorization of the furnished press release and investor presentation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/30/2025 - 08:04 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025

Commission File Number: 001-38097

ARGENX SE

(Translation of registrant’s name into English)

Laarderhoogtweg 25
1101 EB Amsterdam, the Netherlands

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ⌧    Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXPLANATORY NOTE

On October 30, 2025, argenx SE (the “Company’’) issued a press release and investor presentation, copies of which are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated by reference herein.

The information contained in this Current Report on Form 6-K, including Exhibit 99.1 and Exhibit 99.2, shall be deemed to be incorporated by reference into the Company’s Registration Statements on Forms S-8 (File Nos. 333-225375, 333-258253, and 333-274721), and to be part thereof from the date on which this Current Report on Form 6-K is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBITS
Exhibit						Description
99.1						Press Release dated October 30, 2025
99.2						Investor Presentation dated October 30, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

						ARGENX SE
Date: October 30, 2025			By:			/s/ Hemamalini (Malini) Moorthy
						Hemamalini (Malini) Moorthy
						General Counsel